As Sarepta And Valeant Exit Hearings, Biotech Steps Into M&A
Posted: May 2nd, 2016In: Opinions & FeaturesThe last week was a nonstop whirlwind for biotech, so I’ve decided to treat this entry a little differently by commenting on key events and sharing what I’ve been seeing.
Read More about As Sarepta And Valeant Exit Hearings, Biotech Steps Into M&A